Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy.
Robert E GrossMatthew A SternJon T WillieRebecca E FasanoAmit M SaindaneBruno P SoaresNigel P PedersenDaniel L DranePublished in: Annals of neurology (2018)
In an unselected consecutive series of patients, stereotactic laser amygdalohippocampotomy yielded seizure-free rates for patients with mesial temporal lobe epilepsy lower than, but comparable to, the outcomes typically associated with open temporal lobe surgery. Analogous to results from open surgery, patients without mesial temporal sclerosis fared less well. This novel procedure is an effective minimally invasive alternative to resective surgery. In the minority of patients not free of disabling seizures, laser ablation presents no barrier to additional open surgery. Ann Neurol 2018;83:575-587.
Keyphrases
- minimally invasive
- temporal lobe epilepsy
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- coronary artery bypass
- peritoneal dialysis
- prognostic factors
- type diabetes
- adipose tissue
- metabolic syndrome
- patient reported outcomes
- coronary artery disease
- mass spectrometry
- high resolution
- brain metastases